Adjuvant Therapy in High-Risk Renal Cell Cancer: A Systematic Review and Meta-analysis

To perform a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating risk-benefit for adjuvant postoperative treatments in high-risk renal cell carcinoma by assessing reported disease-free survival (DFS), overall survival (OS), toxicity, and quality of life.

Source: Mayo Clinic Proceedings - July 10, 2019 Category: Internal Medicine Authors: Irbaz B. Riaz, Warda Faridi, Muhammad Husnain, Saad Ullah Malik, Qurat Ul Ain R. Sipra, Farva R. Gondal, Hao Xie, Siddhartha Yadav, Manish Kohli Tags: Original article Source Type: research